Zhishui Zheng

631 total citations
15 papers, 279 citations indexed

About

Zhishui Zheng is a scholar working on Molecular Biology, Infectious Diseases and Physiology. According to data from OpenAlex, Zhishui Zheng has authored 15 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Infectious Diseases and 3 papers in Physiology. Recurrent topics in Zhishui Zheng's work include SARS-CoV-2 and COVID-19 Research (4 papers), COVID-19 Clinical Research Studies (4 papers) and IL-33, ST2, and ILC Pathways (2 papers). Zhishui Zheng is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (4 papers), COVID-19 Clinical Research Studies (4 papers) and IL-33, ST2, and ILC Pathways (2 papers). Zhishui Zheng collaborates with scholars based in China and Japan. Zhishui Zheng's co-authors include Shaolin Zeng, Yang Zhao, Tao Wang, Ke Hu, Hanxiang Nie, Xiaojun Wu, Xiaochen Li, Yunting Zhang, Dong Zhao and Yunting Zhang and has published in prestigious journals such as Clinical Infectious Diseases, Annals of the New York Academy of Sciences and Gene.

In The Last Decade

Zhishui Zheng

13 papers receiving 276 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhishui Zheng China 8 171 70 47 45 32 15 279
Feng‐Zeng Li China 8 170 1.0× 76 1.1× 46 1.0× 36 0.8× 29 0.9× 20 284
Lanlan Wei China 7 135 0.8× 42 0.6× 58 1.2× 35 0.8× 21 0.7× 16 253
Davide Negrini Italy 10 373 2.2× 46 0.7× 39 0.8× 63 1.4× 30 0.9× 19 519
Fanfan Zeng China 8 179 1.0× 61 0.9× 72 1.5× 45 1.0× 32 1.0× 20 393
Manli Miao China 5 139 0.8× 88 1.3× 61 1.3× 49 1.1× 27 0.8× 6 279
Yuzhang Wu China 4 279 1.6× 104 1.5× 41 0.9× 49 1.1× 35 1.1× 6 378
Mohamed Yaseen Alsabbagh Iran 4 138 0.8× 63 0.9× 40 0.9× 28 0.6× 89 2.8× 6 285
Ruihua Sun China 6 224 1.3× 102 1.5× 43 0.9× 17 0.4× 42 1.3× 16 342
Jianru Xiao China 3 257 1.5× 100 1.4× 106 2.3× 36 0.8× 14 0.4× 3 385
Salahudeen Mohamed Haja Mohideen Singapore 4 187 1.1× 73 1.0× 41 0.9× 29 0.6× 47 1.5× 7 251

Countries citing papers authored by Zhishui Zheng

Since Specialization
Citations

This map shows the geographic impact of Zhishui Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhishui Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhishui Zheng more than expected).

Fields of papers citing papers by Zhishui Zheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhishui Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhishui Zheng. The network helps show where Zhishui Zheng may publish in the future.

Co-authorship network of co-authors of Zhishui Zheng

This figure shows the co-authorship network connecting the top 25 collaborators of Zhishui Zheng. A scholar is included among the top collaborators of Zhishui Zheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhishui Zheng. Zhishui Zheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Zhao, Yang, et al.. (2023). HSR23-109: Real-World Combination Use of Mogamulizumab With Other Therapies Among Patients With Mycosis Fungoides and Sézary Syndrome. Journal of the National Comprehensive Cancer Network. 21(3.5). HSR23–109.
3.
Zheng, Zhishui, et al.. (2022). Cross‐talk of four types of RNA modification writers defines the immune microenvironment in severe asthma. Annals of the New York Academy of Sciences. 1514(1). 93–103. 7 indexed citations
4.
Zheng, Zhishui, et al.. (2022). Identification of hub genes and potential biomarkers of neutrophilic asthma: evidence from a bioinformatics analysis. Journal of Asthma. 60(2). 348–359. 6 indexed citations
5.
Zeng, Shaolin, et al.. (2022). MicroRNA-98-5p Inhibits IL-13-Induced Proliferation and Migration of Human Airway Smooth Muscle Cells by Targeting RAC1. Inflammation. 45(4). 1548–1558. 5 indexed citations
6.
7.
8.
Ai, Li, Yang Zhao, Tao Wang, et al.. (2021). Diagnostic value of using a combination of nucleic acid and specific antibody tests for SARS-CoV-2 in coronavirus disease 2019. Epidemiology and Infection. 149. e62–e62. 1 indexed citations
9.
Zhao, Yang, Hanxiang Nie, Ke Hu, et al.. (2020). Abnormal immunity of non-survivors with COVID-19: predictors for mortality. Infectious Diseases of Poverty. 9(1). 108–108. 77 indexed citations
10.
Hu, Ke, Yang Zhao, Yunting Zhang, et al.. (2020). A Small-Scale Medication of Leflunomide as a Treatment of COVID-19 in an Open-Label Blank-Controlled Clinical Trial. Virologica Sinica. 35(6). 725–733. 38 indexed citations
11.
Zhao, Dong, Ming Wang, Yang Zhao, et al.. (2020). Asymptomatic infection by SARS-CoV-2 in healthcare workers: A study in a large teaching hospital in Wuhan, China. International Journal of Infectious Diseases. 99. 219–225. 33 indexed citations
12.
Li, Ruiyun, Xiaojun Wu, Yang Zhao, et al.. (2020). Clinical features in 52 patients with COVID-19 who have increased leukocyte count: a retrospective analysis. European Journal of Clinical Microbiology & Infectious Diseases. 39(12). 2279–2287. 49 indexed citations
13.
Zhao, Yang, Weihua Hu, Dong Zhao, et al.. (2020). Treatment of Coronavirus Disease 2019 Patients With Prolonged Postsymptomatic Viral Shedding With Leflunomide: A Single-center Randomized Controlled Clinical Trial. Clinical Infectious Diseases. 73(11). e4012–e4019. 26 indexed citations
14.
15.
Fan, Guohua, Jie Huang, Songping Xie, et al.. (2012). Enhanced oxidation and detection of toxic clenbuterol on the surface of acetylene black nanoparticle-modified electrode. Journal of Molecular Liquids. 169. 102–105. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Feng‐Zeng Li Breakdown of academic impact, for papers by Lanlan Wei Breakdown of academic impact, for papers by Davide Negrini Breakdown of academic impact, for papers by Fanfan Zeng Breakdown of academic impact, for papers by Manli Miao Breakdown of academic impact, for papers by Yuzhang Wu Breakdown of academic impact, for papers by Mohamed Yaseen Alsabbagh Breakdown of academic impact, for papers by Ruihua Sun Breakdown of academic impact, for papers by Jianru Xiao Breakdown of academic impact, for papers by Salahudeen Mohamed Haja Mohideen
Rankless by CCL
2026